Price Chart

Profile

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
URL https://www.alcon.com
Investor Relations URL https://investor.alcon.com/
HQ State/Province N/A
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Large Cap/Growth
Next Earnings Release N/A
Last Earnings Release Aug. 16, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date May. 10, 2023

Profile

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
URL https://www.alcon.com
Investor Relations URL https://investor.alcon.com/
HQ State/Province N/A
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Large Cap/Growth
Next Earnings Release N/A
Last Earnings Release Aug. 16, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date May. 10, 2023